Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths

Why are condo prices falling in major US cities? How will new stablecoin regulations impact fintech? What caused the EPA to slash its workforce? Why did Astronomer's CEO resign after Coldplay concert? How is Trump's tariff policy affecting US auto market? What led to the Trump administration limiting Mexican flights? Why is GM's EV sales growth outpacing Ford's?

Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths

bostonherald.com/2025/07/19/gene-therapy-maker-sarepta-tells-fda-it-wont-halt-shipments-despite-patient-deaths

Drugmaker Sarepta Therapeutics said late Friday it won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a third patient receiving one of its treatments for muscular dystrophy.
The highly unusual move is a…

This story appeared on bostonherald.com, 2025-07-19 19:06:41.